Parenteral Drugs Financials
NSE: PDPL | BSE: 524689
₹2.90
₹0.05
(1.75%)
As on 21-Aug-2023IST
Market cap
₹10 Cr
Revenue (TTM)
₹9 Cr
P/E Ratio
--
P/B Ratio
-0
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
8.54
|
12.17
|
31.87
|
32.01
|
223.91
|
229.75
|
|
|
|
|
|
|
Total Income
|
8.57
|
12.23
|
32.13
|
33.45
|
225.51
|
235.50
|
|
|
|
|
|
|
Total Expenditure
|
24.14
|
23.94
|
46.56
|
49.67
|
225.09
|
252.13
|
|
|
|
|
|
|
EBITDA
|
-15.60
|
-11.77
|
-14.69
|
-17.66
|
-1.17
|
-22.38
|
|
|
|
|
|
|
Depreciation
|
39.52
|
17.33
|
17.35
|
69.12
|
24.24
|
24.89
|
|
|
|
|
|
|
EBIT
|
-55.13
|
-29.10
|
-32.03
|
-86.78
|
-25.42
|
-47.26
|
|
|
|
|
|
|
Interest
|
106.25
|
125.44
|
109.96
|
96.05
|
97.54
|
85.77
|
|
|
|
|
|
|
Other Income
|
0.03
|
0.06
|
0.25
|
1.44
|
1.59
|
5.75
|
|
|
|
|
|
|
Exceptional Items
|
52.21
|
--
|
--
|
--
|
--
|
-0.10
|
|
|
|
|
|
|
Profit before Tax
|
-109.13
|
-154.47
|
-141.74
|
-181.40
|
-121.37
|
-127.39
|
|
|
|
|
|
|
Provision for Tax
|
-32.76
|
-32.76
|
-27.66
|
-33.49
|
-9.56
|
-9.56
|
|
|
|
|
|
|
Profit after Tax
|
-76.36
|
-121.71
|
-114.07
|
-147.91
|
-111.81
|
-117.83
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
-76.36
|
-121.71
|
-114.07
|
-147.91
|
-111.81
|
-117.83
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
-824.03
|
-682.88
|
-561.31
|
-446.92
|
-136.44
|
-17.44
|
|
|
|
|
|
|
Minority Interest
|
--
|
0.12
|
0.12
|
0.12
|
0.28
|
0.28
|
|
|
|
|
|
|
Non-Current Liabilities
|
107.30
|
-58.51
|
-25.79
|
4.47
|
370.10
|
461.57
|
|
|
|
|
|
|
Current Liabilities
|
1,200.84
|
1,143.64
|
1,005.70
|
877.55
|
592.56
|
427.55
|
|
|
|
|
|
|
Total Liabilities
|
484.23
|
568.20
|
551.85
|
540.57
|
890.42
|
913.74
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
409.35
|
334.30
|
351.26
|
367.91
|
727.46
|
750.26
|
|
|
|
|
|
|
Current Assets
|
67.14
|
68.07
|
67.47
|
67.31
|
99.05
|
121.70
|
|
|
|
|
|
|
Total Assets
|
484.23
|
568.20
|
551.85
|
540.57
|
890.42
|
913.74
|
|
|
|
|
|
|
Total Debt*
|
--
|
635.59
|
635.58
|
638.26
|
767.16
|
771.91
|
|
|
|
|
|
|
Net Current Assets
|
-1,133.70
|
-1,075.57
|
-938.24
|
-810.24
|
-493.52
|
-305.85
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
26.28
|
135.04
|
148.35
|
136.27
|
169.07
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
125.32
|
112.36
|
477.03
|
166.95
|
134.40
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
0.06
|
0.08
|
96.58
|
-0.62
|
-0.54
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-125.44
|
-112.43
|
-573.59
|
-166.62
|
-134.35
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-0.05
|
0.01
|
0.02
|
-0.28
|
-0.48
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-47.32
|
-40.82
|
-38.26
|
-49.61
|
-37.50
|
-39.52
|
|
|
|
|
|
|
Cash EPS (₹)
|
--
|
-35.01
|
-32.44
|
-26.42
|
-29.37
|
-31.17
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
--
|
-253.19
|
-212.42
|
-174.06
|
-134.09
|
-94.18
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
42.03
|
37.69
|
159.99
|
55.99
|
45.08
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
10.62
|
9.89
|
165.29
|
32.68
|
19.73
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
--
|
-52.31
|
-35.07
|
-5.55
|
-6.91
|
|
|
|
|
|
|
ROE (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
ROA (%)
|
-14.51
|
-29.65
|
-26.72
|
-23.45
|
-13.17
|
-12.16
|
|
|
|
|
|
|
EBIT Margin (%)
|
-645.79
|
-239.15
|
-100.49
|
-271.08
|
-11.35
|
-20.57
|
|
|
|
|
|
|
Net Margin (%)
|
-891.17
|
-995.10
|
-355.07
|
-442.21
|
-49.58
|
-50.03
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
0.00
|
-857.91
|
-303.46
|
-246.00
|
-38.71
|
-38.86
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-30.00
|
-61.83
|
-0.43
|
-85.70
|
-2.54
|
-11.73
|
|
|
|
|
|
|
EBIT Growth (%)
|
-89.61
|
9.15
|
63.09
|
-241.41
|
46.22
|
19.26
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-15.91
|
-6.70
|
22.88
|
-32.28
|
5.11
|
-1.10
|
|
|
|
|
|
|
EPS Growth (%)
|
37.26
|
-6.70
|
22.88
|
-32.28
|
5.11
|
-1.10
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
-19.19
|
-22.04
|
-29.81
|
-42.37
|
-749.01
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
-0.01
|
-0.01
|
-0.01
|
-0.05
|
-0.12
|
-0.29
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
-43.21
|
-55.08
|
-44.54
|
-40.93
|
1,939.06
|
-51.12
|
|
|
|
|
|
|
Close Price (₹)
|
3.60
|
3.15
|
2.60
|
8.45
|
15.35
|
27.00
|
|
|
|
|
|
|
High Price (₹)
|
5.87
|
3.17
|
9.64
|
18.95
|
32.00
|
46.00
|
|
|
|
|
|
|
Low Price (₹)
|
2.50
|
2.50
|
2.20
|
6.85
|
15.00
|
19.15
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
10.11
|
9.45
|
7.46
|
26.18
|
47.72
|
81.40
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
-0.13
|
-0.84
|
-1.00
|
-1.23
|
-1.92
|
-2.75
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
--
|
--
|
-1.12
|
-8.78
|
|
|
|
|
|
|
Current Ratio
|
0.06
|
0.06
|
0.07
|
0.08
|
0.17
|
0.28
|
|
|
|
|
|
|
Quick Ratio
|
0.06
|
0.06
|
0.07
|
0.07
|
0.12
|
0.18
|
|
|
|
|
|
|
Interest Coverage
|
-0.03
|
-0.23
|
-0.29
|
-0.89
|
-0.24
|
-0.49
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 | Mar-16 | Mar-15 | Mar-14 | Mar-13 | Mar-12 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
--
|
1.64
|
27.13
|
|
|
|
|
|
|
Asset Turnover
|
0.02
|
0.03
|
0.07
|
0.05
|
0.27
|
0.25
|
|
|
|
|
|
|
Receivable days
|
--
|
--
|
--
|
--
|
53.24
|
118.09
|
|
|
|
|
|
|
Inventory Days
|
--
|
42.69
|
29.92
|
176.56
|
58.14
|
77.32
|
|
|
|
|
|
|
Payable days
|
--
|
507.33
|
571.75
|
1,781.63
|
118.85
|
96.59
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-464.64
|
-541.83
|
-1,605.07
|
-7.48
|
98.82
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
